×
About 160 results

ALLMedicine™ Diaphragm Pacing Center

Research & Reviews  50 results

Diaphragm pacing in spinal cord injury can significantly decrease mechanical ventilatio...
https://doi.org/10.1111/aor.14221
Artificial Organs; Onders RP, Khansarinia S et. al.

Mar 1st, 2022 - Cervical spinal cord injury (SCI) can lead to dependence on mechanical ventilation (MV) with significant morbidity and mortality. The diaphragm pacing system (DPS) was developed as an alternative to MV. We conducted a prospective single-arm study ...

Stimulation of both inspiratory plus expiratory muscles versus diaphragm-only paradigm ...
https://doi.org/10.23736/S1973-9087.22.07185-4
European Journal of Physical and Rehabilitation Medicine; Zhao Z, Sun W et. al.

Feb 2nd, 2022 - Chronic obstructive pulmonary disease (COPD), a progressive lung disease, might improve with neuromuscular electrical stimulation. No trials on inspiratory plus expiratory neuromuscular electrical stimulation have been conducted yet. To evaluate t...

Phrenic Nerve Stimulation-Induced Lung ReAeration Trial
https://clinicaltrials.gov/ct2/show/NCT04844892

Dec 17th, 2021 - The PIRAT clinical study is intended to assess the feasibility, safety and effectiveness of transvenous phrenic-nerve-stimulating diaphragm pacing on clinical outcomes in mechanically ventilated patients. By delivering electrical stimulation to th...

A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation
https://clinicaltrials.gov/ct2/show/NCT03783884

Dec 17th, 2021 - The intended patient population is applicable for Lungpacer DPT because there are no noninvasive alternative treatments for patients who are difficult to wean from MV (i.e., ≥96 hours (4 days) on MV) or who have required prolonged MV (>7 days). Th...

An unusual cause of diaphragm pacer failure in congenital central hypoventilation syndr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883077
Journal of Clinical Sleep Medicine : JCSM : Official Publ... Kwon A, Lodge M et. al.

Dec 1st, 2021 - Congenital central hypoventilation syndrome is a rare genetic disorder affecting ventilatory response to hypercapnia and/or hypoxemia. We describe a case of diaphragm pacing (DP) failure in a 38-year-old woman with congenital central hypoventilati...

see more →

Clinicaltrials.gov  9 results

A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation
https://clinicaltrials.gov/ct2/show/NCT03783884

Dec 17th, 2021 - The intended patient population is applicable for Lungpacer DPT because there are no noninvasive alternative treatments for patients who are difficult to wean from MV (i.e., ≥96 hours (4 days) on MV) or who have required prolonged MV (>7 days). Th...

Phrenic Nerve Stimulation-Induced Lung ReAeration Trial
https://clinicaltrials.gov/ct2/show/NCT04844892

Dec 17th, 2021 - The PIRAT clinical study is intended to assess the feasibility, safety and effectiveness of transvenous phrenic-nerve-stimulating diaphragm pacing on clinical outcomes in mechanically ventilated patients. By delivering electrical stimulation to th...

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)
https://clinicaltrials.gov/ct2/show/NCT03107949

May 10th, 2021 - Mechanical ventilation (MV) is a life saving technology but can also cause damage to the lungs and diaphragm such as ventilator induced diaphragmatic dysfunction (VIDD). Research has shown that after being on mandatory MV and sedated the diaphragm...

Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis
https://clinicaltrials.gov/ct2/show/NCT01605006

Mar 27th, 2020 - This is a prospective, non-randomized, open-label, interventional, post-approval (FDA) study of the NeuRx Diaphragm Pacing System (DPS) device. The study will enroll 60 participants who have amyotrophic lateral sclerosis (ALS), meet the FDA-approv...

Follow up Study of Diaphragm Pacing for Patients With High Tetraplegia
https://clinicaltrials.gov/ct2/show/NCT01815554

Jan 31st, 2017 - Ventilatory dependent high tetraplegia is a relatively rare but devastating condition. Review of National Spinal Cord Injury Database statistics show that only 3.6% of patients with tetraplegia are ventilator dependent at one year post injury.1 A ...

see more →

News  5 results

New Method Helps Restore Respiratory Muscle Function in Patients with Spinal Cord Injury
https://www.mdedge.com/fedprac/article/206827/orthopedics/new-method-helps-restore-respiratory-muscle-function-patients?channel=94
Jan Dyer

Aug 21st, 2019 - Many patients with spinal cord injury (SCI) need mechanical ventilatory support. One type of support is diaphragm pacing, which stimulates the diaphragm, helping the person breathe.

New Method Helps Restore Respiratory Muscle Function in Patients with Spinal Cord Injury
https://www.mdedge.com/fedprac/article/206827/orthopedics/new-method-helps-restore-respiratory-muscle-function-patients
Jan Dyer

Aug 21st, 2019 - Many patients with spinal cord injury (SCI) need mechanical ventilatory support. One type of support is diaphragm pacing, which stimulates the diaphragm, helping the person breathe.

Emergency Use Authorization
http://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

Image On this page: About Emergency Use Authorizations (EUAs) EUA Guidance  COVID-19 EUAs In Vitro Diagnostic Products High Complexity Molecular-Based Laboratory Developed Tests SARS-CoV-2 Antibody Tests Personal Protective Equipment and Related M...

Diaphragm Pacing System Gets FDA Nod for ALS
https://www.medscape.com/viewarticle/750718

Sep 30th, 2011 - September 30, 2011 — The US Food and Drug Administration (FDA) has granted approval for the use of the NeuRx Diaphragm Pacing System to aid breathing in patients with amyotrophic lateral sclerosis (ALS). The system is approved for use in patients ...

FDA Grants Humanitarian Use Device Designation for Diaphragm Pacing System in ALS
https://www.medscape.com/viewarticle/730572

Oct 14th, 2010 - October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic lateral sclerosis (ALS) who have a stimulatabl...

see more →